You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 205488


✉ Email this page to a colleague

« Back to Dashboard


NDA 205488 describes NATESTO, which is a drug marketed by Acerus and is included in one NDA. It is available from one supplier. There are five patents protecting this drug. Additional details are available on the NATESTO profile page.

The generic ingredient in NATESTO is testosterone. There are sixty-nine drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 205488
Tradename:NATESTO
Applicant:Acerus
Ingredient:testosterone
Patents:5
Pharmacology for NDA: 205488
Mechanism of ActionAndrogen Receptor Agonists
Medical Subject Heading (MeSH) Categories for 205488
Suppliers and Packaging for NDA: 205488
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NATESTO testosterone GEL, METERED;NASAL 205488 NDA Acerus Pharmaceuticals Corporation 42667-5511 42667-5511-1 1 APPLICATOR in 1 BOX (42667-5511-1) / 11 g in 1 APPLICATOR

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL, METERED;NASALStrength5.5MG/0.122GM ACTUATION
Approval Date:May 28, 2014TE:RLD:Yes
Patent:⤷  Sign UpPatent Expiration:Mar 17, 2034Product Flag?Substance Flag?Delist Request?
Patented Use:NASAL ADMINISTRATION OF A TESTOSTERONE GEL TO A PATIENT TO TREAT THE PATIENT FOR A CONDITION ASSOCIATED WITH A DEFICIENCY OR ABSENCE OF ENDOGENOUS TESTOSTERONE
Patent:⤷  Sign UpPatent Expiration:Feb 4, 2024Product Flag?YSubstance Flag?Delist Request?
Patent:⤷  Sign UpPatent Expiration:Feb 4, 2024Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 205488

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 ⤷  Sign Up ⤷  Sign Up
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 ⤷  Sign Up ⤷  Sign Up
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 ⤷  Sign Up ⤷  Sign Up
Acerus NATESTO testosterone GEL, METERED;NASAL 205488-001 May 28, 2014 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.